Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Applied Dna Scns
(NQ:
APDN
)
0.7829
+0.3436 (+78.22%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
51,228,726
Open
0.4200
Bid (Size)
0.8400 (5)
Ask (Size)
0.8410 (33)
Prev. Close
0.4393
Today's Range
0.4105 - 0.8900
52wk Range
0.3131 - 30.60
Shares Outstanding
10,299,385
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
APDN Stock Earnings: Applied DNA Sciences Reported Results for Q3 2024
August 09, 2024
Applied DNA Sciences just reported results for the third quarter of 2024.
Via
InvestorPlace
Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results
August 08, 2024
Via
ACCESSWIRE
Performance
YTD
-93.69%
-93.69%
1 Month
+91.23%
+91.23%
3 Month
-60.06%
-60.06%
6 Month
-94.25%
-94.25%
1 Year
-97.10%
-97.10%
More News
Read More
Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024
August 07, 2024
Via
ACCESSWIRE
CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit
July 29, 2024
Via
ACCESSWIRE
Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit
July 29, 2024
Via
ACCESSWIRE
Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceability
July 25, 2024
Via
ACCESSWIRE
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing
June 18, 2024
Via
ACCESSWIRE
Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform
June 05, 2024
Via
ACCESSWIRE
U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract
July 18, 2024
Via
ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
July 10, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
July 02, 2024
Via
InvestorPlace
Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics
June 20, 2024
Via
ACCESSWIRE
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health
June 13, 2024
Via
ACCESSWIRE
AMD To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Monday
June 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
June 06, 2024
Via
Benzinga
Crude Oil Rises Sharply; Elbit Systems Shares Fall After Q1 Results
May 28, 2024
Via
Benzinga
Exposures
Fossil Fuels
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 28, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 28, 2024
Via
Benzinga
Dow Dips Over 100 Points; GameStop Shares Spike higher
May 28, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Mixed; Home Prices Increase In March
May 28, 2024
Via
Benzinga
Applied DNA Announces Pricing of $12 Million Public Offering
May 28, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
May 23, 2024
Via
Benzinga
Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
May 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
May 13, 2024
Via
Benzinga
Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML
May 13, 2024
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.